Tian-Shu Liu
Overview
Explore the profile of Tian-Shu Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
1530
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tan Y, Wang Y, Abulipizi A, Ji X, Zhang R, Zhao R, et al.
Eur Heart J Cardiovasc Imaging
. 2024 Dec;
PMID: 39656841
Aims: Noninvasive myocardial work offers a promising echocardiographic method to evaluate left ventricular (LV) function as it integrates myocardial deformation and afterload. The study sought to investigate the association of...
2.
Pei X, Zhang S, Qiu B, Zhang P, Liu T, Wang Y
Pharmaceuticals (Basel)
. 2024 Jul;
17(7).
PMID: 39065799
The interaction between cancer cells and immune cells plays critical roles in gastric cancer (GC) progression and immune evasion. Forced legumain (LGMN) is one of the characteristics correlated with poor...
3.
Cao N, Zhu X, Ma F, Xu Y, Dong J, Qin M, et al.
Chin J Integr Med
. 2024 May;
30(6):489-498.
PMID: 38801641
Objective: To describe the treatment patterns and survival status of advanced gastric cancer (AGC) in China in the past two decades, and objectively evaluate the impact of standardized Chinese medicine...
4.
Wang D, Ren C, Li S, Pat Fong W, Wu X, Xiao J, et al.
PLoS Med
. 2024 May;
21(5):e1004389.
PMID: 38728364
Background: It remains unclear whether intensification of the chemotherapy backbone in tandem with an anti-EGFR can confer superior clinical outcomes in a cohort of RAS/BRAF wild-type colorectal cancer (CRC) patients...
5.
Wang F, Zhang X, Tang L, Wu Q, Cai M, Li Y, et al.
Cancer Commun (Lond)
. 2023 Dec;
44(1):127-172.
PMID: 38160327
The 2023 update of the Chinese Society of Clinical Oncology (CSCO) Clinical Guidelines for Gastric Cancer focuses on standardizing cancer diagnosis and treatment in China, reflecting the latest advancements in...
6.
Hong W, Zhu D, Chen Y, Shen X, Cui Y, Du S, et al.
Cancer Lett
. 2023 Oct;
578:216460.
PMID: 37863352
Coiled-Coil Domain-Containing (CCDC) is a large class of structural proteins containing left-handed supercoiled structure. The clinical value and the functional implication of CCDC in colorectal cancer (CRC) remain unknown. Based...
7.
Wei Y, Zhu J, Wu J, Yu S, Li W, Zhu M, et al.
J Gastrointest Oncol
. 2023 Sep;
14(4):1694-1706.
PMID: 37720426
Background: Trastuzumab (TRA) shows significant efficacy in patients with human epidermal growth factor receptor 2 (HER2)-positive gastric cancer (GC). While TRA can help treat HER2-positive breast cancer, TRA resistance is...
8.
Chen Y, Yang P, Du S, Zhuang Y, Huang C, Hu Y, et al.
World J Gastroenterol
. 2023 Jul;
29(24):3871-3882.
PMID: 37426321
Background: Stereotactic body radiotherapy (SBRT) and programmed cell death 1 inhibitors have shown potential in treating hepatocellular carcinoma (HCC) in retrospective studies. Aim: To evaluate the efficacy of combining SBRT...
9.
Chen Y, Guo X, Liu M, Yu Y, Cui Y, Shen X, et al.
Front Immunol
. 2022 Dec;
13:979521.
PMID: 36569910
Background: Metabolic reprogramming is a feature of cancer. However, colon cancer subtypes based on the glycolysis‒cholesterol synthesis axis have not been identified, and little is known about connections between metabolic...
10.
Zhao S, Yun H, Chen C, Chen Y, Lin J, Zeng M, et al.
Eur J Radiol
. 2022 Oct;
156:110558.
PMID: 36265221
Purpose: Sparse researches evaluated the quantitative cardiovascular magnetic resonance (CMR) parameters for immune checkpoint inhibitors (ICI)-associated myocarditis. We aimed to apply quantitative CMR mappings and late gadolinium enhancement (LGE) extent...